Advances in Drug Development for Arboviral Diseases

Dear Colleagues,

Arboviruses, such as the chikungunya, dengue, Zika, and blue-tongue virus, are responsible for high rates of morbidity and mortality in humans and other animals globally. In recent years, the frequency and severity of arbovirus outbreaks have increased, despite worldwide efforts focusing on vector controls, vaccination programs, and public awareness campaigns. Arboviruses truly are a major public health concern.

Recent advances in drug development have exhibited promise with regard to combatting these arboviral diseases. In this Special Issue, entitled “Advances in Drug Development for Arboviral Diseases”, we invite authors to present their current advancements in the development of antiviral drugs including via innovative techniques, such as high-throughput screening or structure-based drug design, as well as in the development of vaccines. Finally, this Special Issue will offer a global perspective of the current situation with regard to the improvement of curative treatments and the application of preventive measures via vaccination or prophylactic medicines, which will ultimately enable greater means to control arboviral diseases.

Dr. Lara J. Herrero
Dr. Wesley Freppel
Dr. Penny A. Rudd
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Tropical Medicine and Infectious Disease is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• arbovirus
• drug development
• antivirals agents
• therapeutic targets
• vaccine development
• RNA interference
• viral replication
• discovery and development
• lead optimisation
• biomedical research
• novel treatments and cures
• target identification and validation
• mode of action